Details of the Drug Reposition

General Information of This Drug (ID: DM44Z9R)

• Drug Name: BIIB 2024 (DM44Z9R)

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Gastrointestinal stromal tumour	DIS6TJYS	2B5B	Phase 2	[1]
Breast cancer	DIS7DPX1	2C60-2C65	Phase 2	[1]

References

• [1] ClinicalTrials.gov (NCT00574236) Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer. U.S. National Institutes of Health.